FATE
Fate Therapeutics Inc
NASDAQ: FATE · HEALTHCARE · BIOTECHNOLOGY
$1.25
+0.81% today
Updated 2026-04-30
Market cap
$154.63M
P/E ratio
—
P/S ratio
23.27x
EPS (TTM)
$-1.15
Dividend yield
—
52W range
$1 – $2
Volume
1.4M
Fate Therapeutics Inc (FATE) Insider transactions
Net insider activity
Net buying (0 shares)
Buy transactions
0
Sell transactions
0
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|